CFB and lung carcinoma: Our previous study indicated that there is an inverse correlation between Sp1 level and prognosis in clinical lung cancer patients, suggesting that SYK023, but not BA, may be the better therapeutic option for lung cancer, particularly for that without Sp1 accumulation which is associated with poor prognosis [46].